HealthEquity (NASDAQ:HQY) Sets New 1-Year Low Following Analyst Downgrade

Shares of HealthEquity, Inc. (NASDAQ:HQY) reached a new 52-week low on Wednesday after Barclays lowered their price target on the stock from $118.00 to $110.00. Barclays currently has an overweight rating on the stock. HealthEquity traded as low as $72.76 and last traded at $74.36, with a volume of 987588 shares trading hands. The stock had previously closed at $73.88.

HQY has been the topic of several other research reports. Raymond James Financial set a $100.00 price objective on shares of HealthEquity in a research note on Tuesday. Wall Street Zen raised HealthEquity from a “hold” rating to a “buy” rating in a report on Monday, January 19th. BMO Capital Markets reiterated a “market perform” rating on shares of HealthEquity in a research report on Thursday, December 4th. The Goldman Sachs Group lowered HealthEquity from a “neutral” rating to a “sell” rating and set a $89.00 price objective for the company. in a research report on Friday, January 9th. Finally, JPMorgan Chase & Co. upped their price objective on HealthEquity from $126.00 to $129.00 and gave the stock an “overweight” rating in a research note on Thursday, December 4th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating, two have given a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, HealthEquity presently has an average rating of “Moderate Buy” and a consensus price target of $115.60.

Insider Buying and Selling at HealthEquity

In related news, EVP Elimelech Rosner sold 10,959 shares of HealthEquity stock in a transaction dated Thursday, December 18th. The shares were sold at an average price of $95.45, for a total transaction of $1,046,036.55. Following the sale, the executive vice president directly owned 45,742 shares in the company, valued at $4,366,073.90. The trade was a 19.33% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Delano Ladd sold 1,500 shares of the business’s stock in a transaction dated Friday, December 19th. The stock was sold at an average price of $94.72, for a total transaction of $142,080.00. Following the sale, the executive vice president owned 73,979 shares in the company, valued at $7,007,290.88. This trade represents a 1.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 1.50% of the company’s stock.

More HealthEquity News

Here are the key news stories impacting HealthEquity this week:

• Positive Sentiment: Reported record Q4 results and standout fiscal‑2026 sales metrics (HSAs, HSA assets, total accounts); the company reaffirmed its fiscal 2026 and 2027 outlook and published an updated HSA cash repricing schedule — a direct operational/cash‑flow positive update for the HSA business. Read More.
• Positive Sentiment: Raised FY‑2026 EPS guidance to $3.870–$3.950 versus consensus ~$3.69 — this gap to the Street helps justify today’s upward move and supports valuation multiple expansion if execution continues. Read More.
• Positive Sentiment: Analyst commentary and strategy pieces highlight durable HSA volume growth, AI‑driven efficiency gains, and recurring revenue characteristics — factors underpinning long‑term growth stories and investor confidence. Read More.
• Neutral Sentiment: Analyst roundup: coverage from eight analysts provides mixed near‑term views but overall stays constructive; watch for updated consensus estimates and any changes to ratings following the company release. Read More.
• Negative Sentiment: BTIG trimmed its price target from $130 to $110 (still a Buy) — a lower PT reduces upside expectations from some institutional buyers and signals more modest margin for error. Read More.
• Negative Sentiment: Operational risk reminder: analysts flag data security and privacy threats as a meaningful risk for custodial HSA platforms; any adverse incident could meaningfully hurt sentiment and valuation. Read More.

Institutional Investors Weigh In On HealthEquity

Institutional investors and hedge funds have recently modified their holdings of the stock. William Blair Investment Management LLC acquired a new stake in shares of HealthEquity during the fourth quarter valued at approximately $169,956,000. Norges Bank purchased a new position in HealthEquity during the 4th quarter worth approximately $66,927,000. Westfield Capital Management Co. LP raised its stake in HealthEquity by 124.6% during the 2nd quarter. Westfield Capital Management Co. LP now owns 1,265,208 shares of the company’s stock valued at $132,543,000 after purchasing an additional 701,819 shares during the period. AQR Capital Management LLC lifted its holdings in shares of HealthEquity by 148.5% in the second quarter. AQR Capital Management LLC now owns 1,107,448 shares of the company’s stock valued at $116,016,000 after purchasing an additional 661,795 shares in the last quarter. Finally, Millennium Management LLC boosted its position in shares of HealthEquity by 151.5% in the fourth quarter. Millennium Management LLC now owns 951,563 shares of the company’s stock worth $87,173,000 after buying an additional 573,283 shares during the period. 99.55% of the stock is owned by institutional investors and hedge funds.

HealthEquity Stock Up 3.7%

The firm has a market cap of $6.59 billion, a PE ratio of 35.37, a P/E/G ratio of 0.93 and a beta of 0.24. The company has a debt-to-equity ratio of 0.46, a current ratio of 4.13 and a quick ratio of 4.13. The business has a fifty day moving average price of $87.28 and a two-hundred day moving average price of $91.84.

HealthEquity (NASDAQ:HQY) last announced its quarterly earnings data on Wednesday, December 3rd. The company reported $1.01 EPS for the quarter, topping analysts’ consensus estimates of $0.90 by $0.11. The firm had revenue of $322.16 million during the quarter, compared to analyst estimates of $320.92 million. HealthEquity had a return on equity of 12.94% and a net margin of 14.86%.The business’s quarterly revenue was up 7.2% compared to the same quarter last year. During the same period last year, the company posted $0.78 EPS. HealthEquity has set its FY 2026 guidance at 3.870-3.950 EPS. On average, analysts anticipate that HealthEquity, Inc. will post 2.32 EPS for the current fiscal year.

HealthEquity Company Profile

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.